Plain-English translation of NCT06538311 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing repetitive transcranial magnetic stimulation (rTMS), a non-invasive technique that uses magnetic pulses to gently stimulate the part of your brain involved in memory. Researchers want to see whether this treatment can help improve memory and thinking abilities in people with mild cognitive impairment or early memory problems. The study will measure changes in your memory and brain activity using memory tests and brain imaging.
Memory loss and mild cognitive problems are serious concerns for many older adults, and current treatments are limited. This trial explores whether brain stimulation could offer a new way to help people maintain or improve their memory and thinking as they age.
You likely qualify if…
You likely don't qualify if…
You will come in for an initial baseline visit, then return for 10 daily sessions of brain stimulation (Monday through Friday over two weeks), followed by testing to see how you respond. After a two-week break, you will repeat the same cycle: another baseline visit, 10 more days of stimulation, and final testing. Throughout the study, you will have memory tests and brain imaging scans (MRI) to measure any changes in your thinking and brain activity.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States